転移性頭頸部がんの参加者における予防的嚥下訓練の遵守を研究する際の血液検査とアンケート
頭頸部がんにおける予防的嚥下訓練の遵守のモデル化
This trial uses blood tests and questionnaires to study how well participants with head and neck cancer that has spread to other places in the body adhere to swallowing exercises to prevent future disease. Using blood tests to study cytokines (proteins related to the immune system) may help doctors learn if certain levels of cytokines affect whether or not side effects occur and if they put participants at risk for future disease. Questionnaires may help doctors learn about the reasons head and neck cancer participants may or may not follow the swallowing exercises that they are asked to perform after receiving radiation treatments.
調査の概要
状態
状態
条件
条件
- 臨床病期 III HPV 媒介 (p16 陽性) 中咽頭癌 AJCC v8
- III期の下咽頭がんAJCC v8
- III期の喉頭がん AJCC v8
- ステージ III 中咽頭 (p16 陰性) がん AJCC v8
- ステージ IV 下咽頭がん AJCC v8
- ステージ IV 喉頭がん AJCC v8
- ステージ IV 中咽頭 (p16 陰性) がん AJCC v8
- 臨床ステージ I HPV 媒介 (p16 陽性) 中咽頭がん AJCC v8
- 臨床病期 II HPV 媒介 (p16 陽性) 中咽頭癌 AJCC v8
- 病理学的ステージ I HPV 媒介 (p16 陽性) 中咽頭癌 AJCC v8
- 病理学的ステージ II HPV 媒介 (p16 陽性) 中咽頭癌 AJCC v8
- ステージ IV 上咽頭がん AJCC v8
- 病理学的ステージ III HPV 媒介 (p16 陽性) 中咽頭がん AJCC v8
- IVA 期上咽頭がん AJCC v8
- IVB 期上咽頭がん AJCC v8
- ステージ IVA 下咽頭がん AJCC v8
- IVA 期の喉頭がん AJCC v8
- ステージ IVA 中咽頭 (p16 陰性) がん AJCC v8
- ステージ IVB 下咽頭がん AJCC v8
- IVB 期の喉頭がん AJCC v8
- ステージ IVB 中咽頭 (p16 陰性) がん AJCC v8
- 転移性頭頸部がん
- 原発不明のがん
- 子宮頸部の転移性悪性新生物
- ステージ I 下咽頭がん AJCC v8
- ステージ I 上咽頭がん AJCC v8
- ステージ II 下咽頭がん AJCC v8
- II期喉頭がん AJCC v8
- ステージ II 上咽頭がん AJCC v8
- ステージ II 中咽頭 (p16 陰性) がん AJCC v8
- III期の上咽頭がんAJCC v8
介入・治療
介入・治療
詳細な説明
PRIMARY OBJECTIVES:
I. To determine whether illness perceptions significantly predict adherence to swallowing exercises at 6 months after the end of radiation.
II. To determine whether sickness behaviors (depression, fatigue, pain)'s effect on illness perceptions are mediated by pro-inflammatory cytokines.
III. To determine whether social support moderates the impact of coping on appraisal of coping.
SECONDARY OBJECTIVES:
I. As a secondary aim, to determine the feasibility and utility of cardiac impedance pre-ejection period measurement as a corollary measure for depression and distress.
II. As a secondary aim, to identify potential genetic markers for swallowing dysfunction which has developed by the 6-month follow-up.
OUTLINE:
Participants provide blood samples prior to and at the 6-month visit after receiving radiation therapy. Participants also complete questionnaires either at home, in clinic, or via internet over 30 minutes prior to receiving radiation therapy and within 14 days of blood sample collection.
After completion of study, participants are followed up periodically for up to 2 years.
研究の種類
研究の種類
入学 (推定)
入学
連絡先と場所
研究場所
-
-
Texas
-
Houston、Texas、アメリカ、77030
- 募集
- M D Anderson Cancer Center
-
コンタクト:
- Eileen H. Shinn
- 電話番号:713-745-0870
-
主任研究者:
- Eileen H. Shinn
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Participants with head and neck cancer
説明
Inclusion Criteria:
- Are dispositioned to receive radiation with curative intent for nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or an unknown primary cancer with cervical metastases
- Are stage II-IVb for non- human papillomavirus (HPV)- related oropharyngeal cancer
- Have HPV- related oropharynx cancer that is T1, have nodal involvement with no distant metastasis or have HPV- related oropharynx cancer that is at least T2 with no distant metastasis
- Are stage II-IVb for laryngeal cancer
- Are stage I-IVb for hypopharyngeal
- Are stage I-IVb for nasopharyngeal cancer
- Have stage I-III unknown primary cancer with cervical
Exclusion Criteria:
- Have other cancer diagnoses, except non-melanoma skin cancer
- Had treatment for previous head and neck cancer or radiation to the head and neck
- Have a history of previous head and neck surgery (excluding biopsy and/or tonsillectomy and/or tracheotomy)
- Have a current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g., dysphagia due to underlying neurogenic disorder)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
グループ/コホートの数
コホートと介入
グループ/コホートグループ/コホート |
介入・治療介入・治療 |
|---|---|
|
Observational (blood tests, questionnaires)
Participants provide blood samples prior to and at the 6-month visit after receiving radiation therapy. Participants also complete questionnaires either at home, in clinic, or via internet over 30 minutes prior to receiving radiation therapy and within 14 days of blood sample collection. |
Ancillary studies Provide blood samples |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Adherence to swallowing exercises
時間枠:Up to 6 months
|
The primary analytic approach is to use linear mixed models to determine whether illness perceptions significantly predict adherence 6 months. The study will estimate and test the illness perception subscale scores' relationship to adherence using a linear mixed model. In the model, the dependent variable is the patient's self-reported adherence score and independent variables include illness perception, follow-up assessment time point and other covariates such as demographic and medical variables, depression, pain, fatigue, emotional coping, objective coping, appraisal of coping, stress, and lack of social well-being. |
Up to 6 months
|
|
Illness perceptions
時間枠:Up to 6 months
|
The study's statistical tool is mediation analysis: the independent variables are the sickness behaviors (depression, fatigue, pain); the mediators are the cytokine levels, and the outcome variable is illness perception. The study will test the mediator effects based on the product of coefficients method, rather than the classical Baron & Kenny causal steps tests, since the former approach has better statistical power. The study will conduct both single-mediator analysis for each of the mediators, and multiple-mediator analysis with all mediators in the mediating process |
Up to 6 months
|
|
Effect of social support on coping
時間枠:Up to 6 months
|
The moderating effect of social support on coping and appraisal of coping is the statistical equivalent of testing the two-way interaction between these variables and the social support variable. Multivariate linear regression will be used, in which the dependent variable is appraisal of coping at 6 months follow-up, and independent variables include the emotion-focused coping and action-focused sub scales, social support, and their two-way interactions. In the regression, the study will control for baseline variables. In addition, we will also apply the linear mixed model to investigate the moderating effect of these variables longitudinally. The mixed model naturally accounts for the correlation of repeated measures at baseline and 6 months follow-up. |
Up to 6 months
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Eileen H Shinn、M.D. Anderson Cancer Center
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (推定)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- 2016-0597
- 2016-0597 (その他の識別子:M D Anderson Cancer Center)
- NCI-2018-01260 (レジストリ識別子:CTRP (Clinical Trial Reporting Program))
- R21DE019954 (米国 NIH グラント/契約)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。